AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 182 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 6.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $658,000 | +26.3% | 69,957 | +2.6% | 0.00% | – |
| Q2 2020 | $521,000 | +30.9% | 68,157 | +5.7% | 0.00% | – |
| Q1 2020 | $398,000 | -49.2% | 64,457 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $784,000 | +5.4% | 64,457 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $744,000 | +15.5% | 64,457 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $644,000 | -20.6% | 64,457 | +2.4% | 0.00% | 0.0% |
| Q1 2019 | $811,000 | -12.4% | 62,957 | +3.3% | 0.00% | 0.0% |
| Q4 2018 | $926,000 | -27.0% | 60,957 | -3.9% | 0.00% | 0.0% |
| Q3 2018 | $1,269,000 | +2.6% | 63,457 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,237,000 | -3.3% | 63,457 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $1,279,000 | +71.9% | 63,457 | +13.0% | 0.00% | +100.0% |
| Q4 2017 | $744,000 | -28.2% | 56,157 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,036,000 | +0.3% | 56,157 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,033,000 | -18.4% | 56,157 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $1,266,000 | -35.2% | 56,157 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $1,954,000 | +47.2% | 56,157 | +3.7% | 0.00% | +50.0% |
| Q3 2016 | $1,327,000 | -1.2% | 54,157 | -3.6% | 0.00% | 0.0% |
| Q2 2016 | $1,343,000 | +5.9% | 56,157 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,268,000 | -5.1% | 56,157 | +26.9% | 0.00% | -33.3% |
| Q4 2015 | $1,336,000 | -24.0% | 44,257 | 0.0% | 0.00% | -40.0% |
| Q3 2015 | $1,758,000 | -13.7% | 44,257 | +50.0% | 0.01% | 0.0% |
| Q2 2015 | $2,037,000 | +26.4% | 29,500 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $1,612,000 | +105.6% | 29,500 | +60.3% | 0.00% | +33.3% |
| Q4 2014 | $784,000 | +33.6% | 18,400 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $587,000 | +54.1% | 18,400 | 0.0% | 0.00% | +100.0% |
| Q2 2014 | $381,000 | +24.5% | 18,400 | +16.5% | 0.00% | 0.0% |
| Q1 2014 | $306,000 | 0.0% | 15,800 | +25.4% | 0.00% | 0.0% |
| Q4 2013 | $306,000 | +12.9% | 12,600 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $271,000 | -3.2% | 12,600 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $280,000 | – | 12,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |